Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,581 | -7,374 | -18,944 | -10,123 | -5,539 |
| Depreciation Amortization | 115 | 53 | 16 | 106 | 68 |
| Other Working Capital | 233 | -70 | 2,070 | 15 | -152 |
| Other Operating Activity | 1,384 | 629 | 2,785 | 1,902 | 1,022 |
| Operating Cash Flow | $-12,849 | $-6,762 | $-14,073 | $-8,100 | $-4,601 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -47 | -45 | -30 | -54 | -28 |
| Other Investing Activity | -484 | -255 | 0 | -578 | -356 |
| Investing Cash Flow | $-531 | $-300 | $-30 | $-632 | $-384 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 76,865 | N/A | 33,750 | 33,750 | 10,359 |
| Financing Cash Flow | $76,865 | $N/A | $33,750 | $33,750 | $10,359 |
| Beginning Cash Position | 24,212 | 24,212 | 4,565 | 4,565 | 4,565 |
| End Cash Position | 87,697 | 17,150 | 24,212 | 29,583 | 9,939 |
| Net Cash Flow | $63,485 | $-7,062 | $19,647 | $25,018 | $5,374 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,849 | -6,762 | -14,073 | -8,100 | -4,601 |
| Capital Expenditure | -47 | -45 | -30 | -54 | -28 |
| Free Cash Flow | -12,896 | -6,807 | -14,103 | -8,154 | -4,629 |